Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

32 citing papers in PubMed, 51 citations in OpenAlex.

1. HIV-1 Vpr Drives a B Cell-Like Phenotype in Primary CD4MedComm · 2026
   Article
2. Identification of inducible HIV reservoirs in tonsillar, intestinal and cervical tissue models of HIV latency.Nature communications · 2025
   Article
3. Description of T-Cell and Monocyte Populations in the Circulation of People with HIV Prior to AIDS-NHL Diagnosis.Cells · 2025
   Article
4. CD20-bearing extracellular vesicles are associated with prognostic biomarkers of patients with AIDS-NHL.Scientific reports · 2025
   Article
5. Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.Current HIV/AIDS reports · 2025
   Review
6. The hypoxia-regulated ectonucleotidase CD73 is a host determinant of HIV latency.Cell reports · 2023
   Article
7. KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir.Cell reports. Medicine · 2023
   Article
8. Lymph-Node-Based CD3Journal of virology · 2023
   Article
9. Antigen specificities of HIV-infected cells: A role in infection and persistence?Journal of virus eradication · 2023
   Review
10. HIV-1 remission and possible cure in a woman after haplo-cord blood transplant.Cell · 2023
    Article
11. Phenotypic characterization of single CD4+ T cells harboring genetically intact and inducible HIV genomes.Nature communications · 2023
    Article
12. Profound phenotypic and epigenetic heterogeneity of the HIV-1-infected CD4Nature immunology · 2023
    Article
13. CD20Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Review
14. Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response.eLife · 2022
    Article
15. Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy.mBio · 2021
    Article
16. CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties.Scientific reports · 2021
    Article
17. Flow-FISH as a Tool for Studying Bacteria, Fungi and Viruses.Biotech (Basel (Switzerland)) · 2021
    Review
18. The Contributions of Clinical Pharmacology to HIV Cure Research.Clinical pharmacology and therapeutics · 2021
    Review
19. HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies.Cells · 2021
    Review
20. Residual Proviral Reservoirs: A High Risk for HIV Persistence and Driving Forces for Viral Rebound after Analytical Treatment Interruption.Viruses · 2021
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

20 authors at 2 institutions in 1 country.

Funding

Abstract

Indexed as